Lantheus Holdings
- In Vitro and In Vivo Diagnostic Substances
- North Billerica, Massachusetts
Compensation history
Top executives at Lantheus Holdings received an average of $1M per person in annual compensation from 2014 to 2020.
By year
- 2019
MH$4MMary Anne HeinoPresident and Chief Executive OfficerRM$1MRobert J. Marshall, JrChief Financial OfficerMD$1MMichael DuffySenior Vice President, Law and Public Policy and General CounselCO$1MCesare OrlandiFormer Chief Medical OfficerJB$1MJohn BollaChief Operations OfficerSR$1MSimon RobinsonSenior Vice President, Research and Pharma Development
Executives
We found ten executives who work or worked at Lantheus Holdings.
John Bolla
Lantheus Holdings
Chief Operations Officer
Michael Duffy
Lantheus Holdings
General Counsel
Istvan Molnar
Lantheus Holdings
Chief Medical Officer
Mary Heino
Lantheus Holdings
Chief Executive Officer
Robert Marshall
Lantheus Holdings
Chief Financial Officer
Simon Robinson
Lantheus Holdings
Senior Vice President, Research and Pharma Development
Cesare Orlandi
Lantheus Holdings
Chief Medical Officer
John Crowley
Lantheus Holdings
Chief Financial Officer
News
About Lantheus Holdings
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- In Vitro and In Vivo Diagnostic Substances
- 331 Treble Cove Road, North Billerica, Massachusetts 01862
- 978 671-8001
- December 31
- Former names
- Lantheus MI Holdings, Inc.